Director, Global Business Development Forecasting

Director, Global Business Development Forecasting

Abb Vie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas immunology, oncology, neuroscience, and eye care and products and services in our Allergan Aesthetics portfolio. For more information about Abb Vie, please visit us at  Follow @abbvie on X, Facebook, Instagram, You Tube, Linked In and Tik Tok.

Abb Vie is searching for a strategic, deal-oriented, intellectually-curious healthcare analytics professional to lead forecasting in support of Abb Vie’s Business Development efforts. This role also partners close with Abb Vie’s Pipeline Commercialization & Strategy (PCS) Forecasting team to implement modeling and analytics enhancements, and to ensure close alignment between BD and Pipeline forecasts.

The successful candidate will have at least ten years of healthcare commercial analytics/finance experience ideally in pharmaceuticals and will have expertise in a broad range of data sources and analytical techniques. This individual will leverage clinical and commercial insights, competitive and market analysis, syndicated secondary data sources, and primary research in the development of strategic revenue forecasts and commercial P&Ls that inform strategic decision making and the negotiation of acquisitions, partnerships, and licensing agreements.

This individual will be a true strategic partner in the BD commercial assessment process and will provide perspective on how each opportunity will align with and support the therapeutic area strategy.

This role requires strong analytical and financial acumen, intellectual curiosity, flexibility, comfort with ambiguity, the ability to develop recommendations with incomplete information, and the management of multiple, simultaneous work streams.

The individual in this role will report to the Director, Forecasting COE and leads a team of ~3-5 forecasters.

The primary responsibility of this role is to lead the team that develops net sales forecasts and commercial P&Ls to support assessment of external business development opportunities. The team has accountability for BD forecasting across all of Abb Vie’s therapeutic areas.

• Develop and maintain knowledge of key commercial and scientific trends in key therapeutic areas. Partner with commercial leadership to establish the vision for what these markets might look like in the future, and how Abb Vie can best leverage external partnerships to advance these markets and treatments.
• Remain abreast of industry and therapeutic area trends by reviewing analyst reports, primary and secondary market research, clinical study results, competitor profiles, promotional activity levels, pricing, and scientific literature.
• Establish relationships with internal partner functions outside of PCS/BD to support development of forecast assumptions. Partner functions include but are not limited to Business Development, Search and Evaluation, Analytics & Performance Excellence (APEX), PCS Price Forecasting, and Global Epidemiology.

• Design, build, and operate forecast models.
• Develop competitive intelligence and become the key source of information on the project and the future marketplace dynamics.
• Partner with APEX to shape primary research activities and conduct secondary data searches.
• Develop therapeutic area overviews, market assessments and forecasts for future product opportunities.
• Provide fact-based commercial analysis utilizing primary and secondary market research and opinion leader input to support go/no‑go decisions.
• Forecast product sales and profits under various scenarios that consider alternative strategies and risks.
• Identify, and articulate uncertainties in forecast assumptions, and quantify potential downside risk and upside opportunity.
• Partner with internal stakeholders to align on key P&L assumptions.
• Provide P&L support for the broader…